Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06157801 · ClinicalTrials.gov registry record
Evaluation of Hereditary Cancer Educational Videos
A clinical trial of Hereditary Cancer, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 43
- Enrollment target
- 1
- Study location
NCT06157801: Active study of Hereditary Cancer, sponsored by M.D. Anderson Cancer Center.
NCT06157801 is a study of Hereditary Cancer that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 43 participants, below the 271-participant average among 3 other Hereditary Cancer trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06157801, a study of Hereditary Cancer, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn if educational videos can help participants be more informed about hereditary cancers (ones that run in the family).
Primary Outcome
Hereditary Cancer Multidimensional Measure of Informed Choice (MMIC) Knowledge Score scale: (1-8) true or false
Conditions Studied
Interventions
- BEHAVIORAL Interview Study
- BEHAVIORAL Survey Study
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2024-04-05 |
| Est. Completion | 2027-10-31 |
What the registry record for NCT06157801 still lists
NCT06157801 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 271-participant average among 3 other Hereditary Cancer trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Hereditary Cancer appearing as the primary indexed condition, and to 2 interventions - of which Interview Study is the first listed.
NCT06157801 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06157801 about?
NCT06157801 is a clinical study titled "Evaluation of Hereditary Cancer Educational Videos". To learn if educational videos can help participants be more informed about hereditary cancers (ones that run in the family).
What is the current status of trial NCT06157801?
This trial is currently active not recruiting. The enrollment target is 43 participants. The study started on 2024-04-05. Estimated completion is 2027-10-31.
What conditions does trial NCT06157801 study?
This clinical trial studies the following conditions: Hereditary Cancer.
What interventions are being tested in trial NCT06157801?
The interventions under investigation include: Interview Study (BEHAVIORAL), Survey Study (BEHAVIORAL).
Who is sponsoring clinical trial NCT06157801?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06157801 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hereditary Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI